Published in Urol Clin North Am on May 01, 1984
Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol (2009) 2.88
Platinum-based chemotherapy for variant castrate-resistant prostate cancer. Clin Cancer Res (2013) 1.53
Diagnosis of prostate cancer via nanotechnological approach. Int J Nanomedicine (2015) 0.77
Metastatic renal tumor presenting as ovarian clear cell carcinoma. Urology (1993) 1.57
Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer (1995) 1.47
Metastases to the eye from transitional cell carcinoma of the bladder. J Urol (1975) 1.23
Prevalence and significance of prostatic inflammation. J Urol (1981) 1.23
Treatment of stage IV carcinoma of the prostate. Urol Clin North Am (1975) 1.15
Morbidity and mortality of renal exploration for cyst. Surg Gynecol Obstet (1967) 1.15
Carcinoma of the male urethra. J Urol (1967) 1.15
Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol (1997) 1.11
The role of excretory urography and cystoscopy in the evaluation and management of women with recurrent urinary tract infection. J Urol (1980) 1.07
Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol (1990) 1.06
Etiology of benign prostatic hyperplasia. Urol Clin North Am (1995) 1.04
The natural history of simple renal cysts: a preliminary study. J Urol (1986) 1.00
Analgesia and hyperreactivity produced by intracranial microinjections of morphine into the periaqueductal gray matter of the rat. Behav Biol (1974) 0.99
Partial inhibition of castration induced ventral prostate regression with actinomycin D and cycloheximide. Invest Urol (1978) 0.96
Touch preparation cytological evaluation of radical prostatectomy specimens. J Urol (1994) 0.95
Simultaneous diversion of the urinary and fecal streams utilizing a single abdominal stoma: the double-barreled wet colostomy. J Urol (1989) 0.92
Advanced prostatic carcinoma. Early versus late endocrine therapy. Urol Clin North Am (1991) 0.90
The accuracy of diagnostic biopsy specimens in predicting tumor grades by Gleason's classification of radical prostatectomy specimens. J Urol (1984) 0.90
Palliative urinary diversion for malignant ureteral obstruction. J Urol (1978) 0.89
Radiographic assessment of the vesicourethral anastomosis directing early decatheterization following nerve-sparing radical retropubic prostatectomy. J Urol (1989) 0.89
Radiation therapy in the treatment of carcinoma of the prostate. J Urol (1971) 0.89
Growth factors in expressed prostatic fluid from men with prostate cancer, BPH, and clinically normal prostates. Prostate (1999) 0.87
Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate (1997) 0.86
Activities of cathepsin D in rat prostate during castration induced involution. J Urol (1982) 0.85
Carcinoma of the prostate. Hormonal therapy. Cancer (1987) 0.85
Analysis of specific proteins in prostatic fluid for detecting prostatic malignancy. J Urol (1979) 0.85
Elevated rate of 3H-uridine incorporation in regressing rat ventral prostate. Invest Urol (1978) 0.84
The effect of orchiectomy and estrogens of benign prostatic hyperplasia. J Urol (1972) 0.83
Acid phosphatase. Urol Clin North Am (1979) 0.83
Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate. Prostate (1983) 0.82
Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Cancer Res (1980) 0.82
Acid ribonuclease in rat prostate during castration-induced involution. Biol Reprod (1980) 0.82
Non-androgenic role of testis in enhancing ventral prostate growth in rats. Prostate (1990) 0.82
The double-barreled wet colostomy: long-term experience with the first 11 patients. J Urol (1994) 0.81
Simultaneous abdominal aortic aneurysm repair and nephrectomy for neoplasm. Am J Surg (1995) 0.80
Evidence for a non-androgenic role of testis and epididymis in androgen-supported growth of the rat ventral prostate. J Urol (1992) 0.80
Extraction of a substance with prolactin-like and growth hormone-like properties from ovine testes: preliminary communication. J Urol (1967) 0.80
Action of prolactin in regressing prostate: independent of action mediated by androgen receptors. Prostate (1984) 0.80
High fat diet increases the weight of rat ventral prostate. Prostate (2001) 0.80
Reversed seromuscular flaps in the urinary tract in dogs. J Urol (1994) 0.80
Epidermal growth factor-related peptides in human prostatic fluid: sources of variability in assay results. Prostate (1997) 0.79
Effect of testosterone-estradiol administration on citric acid and fructose content of the rat prostate. Endocrinology (1965) 0.79
Differential growth rates in stromal cultures of human prostate derived from patients of varying ages. Prostate (1999) 0.79
Ureteroscopic results and complications: experience with 130 cases. J Urol (1988) 0.78
Two-dimensional characterization of prostatic acid phosphatase, prostatic specific antigen and prostate binding protein in expressed prostatic fluid. Prostate (1986) 0.78
Systematic characterization of human prostatic fluid proteins with two-dimensional electrophoresis. Clin Chem (1984) 0.78
Adjuvant doxorubicin hydrochloride and radiation in stage D bladder cancer: a preliminary report. J Urol (1984) 0.77
Corpora cavernosa-glans penis shunt for priapism. Surg Gynecol Obstet (1981) 0.77
Analysis of prostatic fluid in prostatic disease. Cancer Treat Rep (1977) 0.77
Adjuvant radiation therapy in stages C and D1 prostatic adenocarcinoma: preliminary results. Urology (1986) 0.77
Cytological atypia in the prostate gland: frequency, distribution and possible relevance to carcinoma. J Urol (1986) 0.76
Effect of testosterone, dihydrotestosterone, estradiol, and prolactin on the weight and citric acid content of the lateral lobe of the rat prostate. Invest Urol (1976) 0.76
The effect of CIS hydroxyproline on ventral prostatic growth in rats. J Urol (1983) 0.76
Priapism in boys. Management with cavernosaphenous shunt. Urology (1975) 0.76
A local direct effect of pituitary graft on growth of the lateral prostate in rats. Prostate (1992) 0.75
Adjuncts to renal preservation. Surg Forum (1969) 0.75
Morbidity of pelvic lymphadenectomy. Urology (1979) 0.75
Efficacy of polyglycolic acid (PGA) tubing stents in ureteroureterostomies. Urol Res (1984) 0.75
In vitro perfusion of the canine prostate. Invest Urol (1975) 0.75
Diagnosis of carcinoma of prostate. Urology (1981) 0.75
DNA profile of nephrogenic adenoma assessed by flow cytometry. Urology (1993) 0.75
Detection of carcinoma of the prostate utilizing biochemical observations. Cancer (1980) 0.75
Correlation of ABH antigenicity and urine cytology results in transitional cell carcinoma of bladder. Urology (1984) 0.75
Morbidity and mortality of renal exploration for cyst. Surg Gynecol Obstet (1977) 0.75
Effect of spermatocele fluid on growth of human prostatic cells in culture. J Androl (1993) 0.75
Prostatic carcinoma: management. J Urol (1984) 0.75
Ureterolymphatic backflow. J Urol (1978) 0.75
Vasovasostomy in rabbits using fibrin adhesive prepared from a single human source. J Urol (1993) 0.75
Lactate dehydrogenase isoenzymes in human prostatic fluid: an aid in recognition of malignancy? J Urol (1977) 0.75
Unilateral renal papillectomy via laser or incisional techniques: chronic functional effects in the dog. Urology (1994) 0.75
Effect of 2-bromo-alpha-ergocryptine (CB-154) on estrogen induced growth of the rat prostate. Invest Urol (1978) 0.75
Evaluation of prostatic fluid in prostatic pathology. Prog Clin Biol Res (1981) 0.75
Epididymal metastasis from prostatic carcinoma. Urology (1985) 0.75
Ureterosigmoidostomy in rats: a model for the study of bladder tumour carcinogenesis and cocarcinogenesis. Urol Res (1979) 0.75
Re: the cell surface antigens of bladder washing specimens in patients with bladder tumors: a new approach. J Urol (1980) 0.75
Radiation therapy in the treatment of carcinoma of the prostate. Trans Am Assoc Genitourin Surg (1970) 0.75
Treatment of stage D bladder cancer with adjuvant doxorubicin hydrochloride and radiation. Urology (1982) 0.75
Metabolic action of prolactin in regressing prostate: independent of androgen action. Prostate (1985) 0.75
Incorporation and release of tritiated leucine in rat prostate during castration induced involution. Invest Urol (1981) 0.75
Metabolic inhibitors and renal ischemia. Invest Urol (1971) 0.75
Endocrine therapy in the management of advanced prostatic cancer: the case for early initiation of treatment. Urol Clin North Am (1980) 0.75
Symposium on renal lithiasis. Simple and extended pyelolithotomy. Urol Clin North Am (1974) 0.75
Human renal transplantation. Surg Clin North Am (1966) 0.75
PR92 antigen in human prostate fluid: elevated levels in prostate cancer. Prostate (1994) 0.75
Partial inhibition of castration-induced involution in rat prostate by chloroquine. A preliminary observation. Invest Urol (1979) 0.75
Extensive suprapubic vesicocutaneous fistula following trauma. J Urol (1981) 0.75
Detection of prostatic cancer. Cancer Chemother Rep (1975) 0.75
Abnormal flow cytometry profiles in patients with interstitial cystitis. J Urol (1994) 0.75
Effect of prolactin on testosterone uptake by the perfused canine prostate. Surg Forum (1974) 0.75
Estimation of canine prostatic size by in vivo ultrasound and volumetric measurement. J Urol (1985) 0.75
The effect of testicular irradiation on established BPH in the dog: evidence of a non-steroidal testicular factor for BPH maintenance. J Urol (1985) 0.75
Prostatic fluid lactic dehydrogenase isoenzyme patterns of prostatic cancer and hyperplasia. J Urol (1975) 0.75
Delay of castration induced regression in rat prostate by pituitary homografts. J Urol (1982) 0.75
Radiation therapy for carcinoma of the prostate 5-year followup. J Urol (1977) 0.75
Inferior vena cava obstruction secondary to adenocarcinoma of the prostate. Role of orchiectomy in treatment. Arch Intern Med (1986) 0.75
Transrectal ultrasound in the repair of the post-traumatic urethra. J Urol (1991) 0.75